Hemophilia B Drug Market Size and Share to Grow by 2032, Assesses DelveInsight | Key Emerging Therapies - CSL222, SerpinPC, AskBio009, PF-06838435/fida, Marstacimab, FLT180a, Concizumab, Fitusiran
March 27, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 27, 2024 (GLOBE NEWSWIRE) -- Hemophilia B Drug Market Size and Share to Grow by 2032, Assesses DelveInsight | Key Emerging Therapies - CSL222, SerpinPC, AskBio009,...
Hemophilia Market To Reach USD 16.84 Billion By 2026 | Reports And Data
December 03, 2019 10:55 ET
|
Reports and Data
New York, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Rising incidences of hemophilia, increasing awareness, technological advancements, strategic developments by key market players such as partnerships and...